Early recognition and treatment strategies for fibrotic interstitial lung disease in China
Official title: Fibrotic Interstitial Lung Disease Early Recognition and Strategic Therapy Study in China
Run by China-Japan Friendship Hospital · NCT06655090 · Data updated 2026-11-12
This study is trying to find better ways to recognize and treat fibrotic interstitial lung disease in China by looking at a large group of patients and testing new methods for diagnosis and treatment.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 10000 (estimated) |
| Sponsor | China-Japan Friendship Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | December 1, 2021 |
| Main results expected | November 30, 2024 |
| Study ends | November 30, 2027 |
| Registry record updated | October 23, 2024 |
| Trial ID | NCT06655090 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals diagnosed with interstitial lung disease.
✕Probably not a fit
Patients who lack a chest CT or refuse to participate will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project aims to create a large cohort of over 10,000 cases of fibrotic interstitial lung disease (f-ILD), including a significant number of pneumoconiosis cases, to study clinical phenotypes associated with pulmonary fibrosis. The study will evaluate the safety and effectiveness of various biopsy techniques and optimize histological diagnosis methods for f-ILD. Additionally, it will develop an artificial intelligence system for assessing the severity of pulmonary fibrosis and identify important molecular targets and biomarkers. The ultimate goal is to establish early recognition models and intervention strategies for f-ILD that can be applied nationwide.
Why it matters
Potential benefit: If successful, this study could lead to improved early detection and treatment strategies for patients with fibrotic interstitial lung disease.
How similar studies have gone: Other studies have shown success in utilizing similar approaches for early recognition and treatment of interstitial lung diseases, indicating potential for this study.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed as ILD Exclusion Criteria: * Lack of chest CT * Patients refused to participant
Where it's running
-
China-Japan Friendship Hospital
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Study coordinator: Huaping Dai, M.D. Ph.D.
- Email: daihuaping@sina.com
- Phone: 0086-10-84206271
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Chronic Respiratory Disease Participant Engagement
This study tests whether adults with long-term lung conditions can get comfortable with a clinical trials unit and research team before joining future trials.
-
Photon-counting CT vs standard HRCT to help diagnose IPF and other ILDs
This study tests whether photon-counting CT can improve identifying IPF and other ILDs compared with standard HRCT for patients discussed in multidisciplinary teams.
-
Finger vs. Earlobe Pulse Oximetry During a 6-Minute Walk Test in ILD
This study tests whether finger or earlobe pulse oximetry gives the same oxygen saturation readings during a 6-minute walk in people with interstitial lung disease.
-
Tele-Pulmonary Rehabilitation for Chronic Lung Diseases
This study tests whether a remote tele-rehabilitation program helps people with chronic lung diseases start and stick with pulmonary rehab better than usual center-based care.
-
Breathlessness in respiratory diseases: who feels it and why
This study tests how physiology, psychology, function, and breathing patterns relate to breathlessness in people with respiratory conditions compared with healthy controls.
-
Non-invasive tests to help ILD diagnosis and prognosis in pigeon fanciers and ILD patients
Aims to see if easy blood and breath tests can help diagnose and predict outcomes for interstitial lung disease, starting with pigeon fanciers at risk and then extending to ILD patients.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.